After Back to Back Winners, Look at LXRP for Tomorrow

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

SmallCapVoice Newsletter

BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.


Two 30% or more gainers on last two picks. We think LXRP is set up nicely for a great day tomorrow! —————————————————————– Hot Stock to Watch —————————————————————– Company: Lexaria Corp. (OTCQB: LXRP) Last:

Price: 0.1065 Change (%): + 0.0115 (12.10) Volume: 348,908 Lexaria Updates Burlington License Application KELOWNA, BC / ACCESSWIRE / December 9, 2014 / Lexaria Corp.

(OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce progress on the Burlington, Ontario MMPR license application.

Health Canada has advised our joint venture partner Enertopia Corp (ENRT) that the Burlington, Ontario application has advanced to the Enhanced Screening Stage of the application process.

The Burlington Joint Venture with Enertopia Corp originally applied in July 2014 to produce 10,000kg of Medical Marihuana per year under its Licensed Producer application. Enertopia has 51% interest in the joint venture and Lexaria Corp 49% as earlier released.

Health Canada has noted the following steps in processing an application. Note there are no specific process times for each step:

Step 1: Preliminary Screening (Completed) Step 2: Enhanced Screening (Underway) Step 3: Security Clearance Step 4: Review Step 5: Ready to build letter (if required by applicant) Step 6: Pre-licence inspection Step 7: Licensing The current application is thorough and has been considerably improved by improvements made during the Preliminary Screening process, which has now been completed. The Burlington JV has requested a Ready To Build letter from Health Canada once the application has completed step 4 of the approval process.

Continue Reading – —————————————————————– IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY —————————————————————– SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies.

You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research.

You are receiving this message because you have agreed to receive emails from opt out of our distribution list at any time by clicking on the “

This entry was posted in SmallCapVoice and tagged , , . Bookmark the permalink.

Comments are closed.